Transillumination Light Scanning or Diaphanography Form

Chat with GenHealth to automate any policy or prior auth task.

Effective Date

01/01/2066

Last Reviewed

NA

Original Document

  Reference



Background for this Policy

While transillumination light scanning, or diaphanography, for use in detection of cancer and other diseases of the breast, appears safe, the usefulness of this instrumentation, when compared to existing modes of cancer and other breast disease detection, has not clearly been established.

Further study of this technology is needed to determine its role in breast cancer diagnosis. Program payment may not be made for this procedure at this time.

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.